Jay S. Stout, Chief Technology Officer at Immunovant, Inc. (IMVT), sold 14,478 shares at $28.90 ($418K) on 2024-04-24, disclosed to the SEC on 2024-04-26.
Open-market sale of $418k IMVT by Chief Technology Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $28.90 | 7,239 | $209K | 50.0% |
| 2 | $28.90 | 7,239 | $209K | 50.0% |
| Total | $28.90 avg | 14,478 | $418K | 100% |
| Filing → |
| IMVT | SELL | 2026-06-26 | $1.5M | — | Filing → |
| IMVT | SELL | 2026-04-24 | $82K | — | Filing → |
| IMVT | SELL | 2026-04-10 | $252K | — | Filing → |